Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors
Darin J Gustin, Clark A Sehon, Jianmei Wei, et al.
Molecular Cancer Therapeutics
|
March 19, 2008
A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker
Shelby Crawford, Daniel Belajic, Jianmei Wei, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
Kristen L Arienti, Anders Brunmark, Frank U Axe, et al.
Nature
|
July 29, 2011
Oxysterols direct B-cell migration through EBI2
Changlu Liu, Xia V Yang, Jiejun Wu, et al.
Plos One
|
May 23, 2018
Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study
Martin Andersen, Mikael Boesen, Karen Ellegaard, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands
Alice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors
Cheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton
Navin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Arthritis Research & Therapy
|
June 3, 2014
Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study
Martin Andersen, Mikael Boesen, Karen Ellegaard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
Robin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors
Darin J Gustin, Clark A Sehon, Jianmei Wei, et al.
Molecular Cancer Therapeutics
|
March 19, 2008
A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker
Shelby Crawford, Daniel Belajic, Jianmei Wei, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
Kristen L Arienti, Anders Brunmark, Frank U Axe, et al.
Nature
|
July 29, 2011
Oxysterols direct B-cell migration through EBI2
Changlu Liu, Xia V Yang, Jiejun Wu, et al.
Plos One
|
May 23, 2018
Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study
Martin Andersen, Mikael Boesen, Karen Ellegaard, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands
Alice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors
Cheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton
Navin L Rao, Paul J Dunford, Xiaohua Xue, et al.
Arthritis Research & Therapy
|
June 3, 2014
Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study
Martin Andersen, Mikael Boesen, Karen Ellegaard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties
Robin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Page
of 8